Raymond James & Associates’s NewAge, Inc. Common Stock (Delaware) NBEV Stock Holding History
Bought
Maintained
Sold
Other funds holding NBEV
SM
RCM
TRCT
TAM
Raymond James & Associates's NBEV Position: Q3 2022 in Review
Raymond James & Associates sold out of NewAge, Inc. Common Stock (Delaware) (NBEV) in Q3 2022, closing a stake of 29,179 shares — an estimated $7K sold.
Raymond James & Associates first reported a position in NBEV in Q3 2018 and held it in 16 quarters. The position peaked at $1.07M in Q2 2019. 12 funds tracked by Wall St. Rank hold NBEV as of Q3 2022.
- Raymond James & Associates reported no remaining NewAge, Inc. Common Stock (Delaware) position as of Q3 2022 after selling out during the quarter.
- Raymond James & Associates sold 29,179 NewAge, Inc. Common Stock (Delaware) shares in Q3 2022, an estimated $7K.
- Raymond James & Associates first reported a position in NewAge, Inc. Common Stock (Delaware) in Q3 2018 and held it in 16 quarters.
- Raymond James & Associates's NewAge, Inc. Common Stock (Delaware) position peaked at $1.07M in Q2 2019.
- 12 funds tracked by Wall St. Rank held NewAge, Inc. Common Stock (Delaware) as of Q3 2022.
Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.